Dr. Mehmet Oz holds millions of dollars worth of shares in health insurance, fertility, pharmaceutical and vitamin companies. That's according to a newly released government ethics report on the celeb ...

There are two significant, nonscientific obstacles – a shortage of funding and patent law – that will require concerted effort by scientists, concerned citizens, society and our lawmakers to overcome.

For healthcare companies, adopting a business-to-business (B2B) model and working with larger companies can help spearhead ...